Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 2
2008 4
2009 1
2010 1
2011 1
2012 5
2013 7
2014 10
2015 14
2016 10
2017 12
2018 13
2019 17
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 31722915

98 results
Results by year
Filters applied: . Clear all
Page 1
Navigating cannabinoid choices for chronic neuropathic pain in older adults: Potholes and highlights.
Kamrul R, Bunka D, Crawley A, Schuster B, LeBras M. Kamrul R, et al. Can Fam Physician. 2019 Nov;65(11):807-811. Can Fam Physician. 2019. PMID: 31722915 Free PMC article. No abstract available.
Brief Commentary: Cannabinoid Dosing for Chronic Pain Management.
Boehnke KF, Clauw DJ. Boehnke KF, et al. Ann Intern Med. 2019 Jan 15;170(2):118. doi: 10.7326/M18-2972. Epub 2019 Jan 8. Ann Intern Med. 2019. PMID: 30615778 No abstract available.
The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
Boychuk DG, Goddard G, Mauro G, Orellana MF. Boychuk DG, et al. J Oral Facial Pain Headache. 2015 Winter;29(1):7-14. doi: 10.11607/ofph.1274. J Oral Facial Pain Headache. 2015. PMID: 25635955 Review.
Neuropathic and non-neuropathic chronic pain at GP encounters: Prevalence, patient characteristics, suffering and pregabalin use.
Henderson J, Pollack AJ, Pan Y, Miller GC. Henderson J, et al. Aust Fam Physician. 2016 Nov;45(11):783-786. Aust Fam Physician. 2016. PMID: 27806445 Free article. No abstract available.
Are cannabinoids effective for orofacial pain states?
Sessle BJ. Sessle BJ. J Oral Facial Pain Headache. 2015 Winter;29(1):5-6. doi: 10.11607/ofph.2015.1.e. J Oral Facial Pain Headache. 2015. PMID: 25715439 No abstract available.
[Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F, Enax-Krumova EK, Häuser W. Petzke F, et al. Schmerz. 2016 Feb;30(1):62-88. doi: 10.1007/s00482-015-0089-y. Schmerz. 2016. PMID: 26830780 Review. German.
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Häuser W, Petzke F, Fitzcharles MA. Häuser W, et al. Eur J Pain. 2018 Mar;22(3):455-470. doi: 10.1002/ejp.1118. Epub 2017 Oct 15. Eur J Pain. 2018. PMID: 29034533
How effective is ketamine in the management of chronic neuropathic pain?
Shteamer JW, Callaway MA, Patel P, Singh V. Shteamer JW, et al. Pain Manag. 2019 Nov;9(6):517-519. doi: 10.2217/pmt-2019-0032. Epub 2019 Oct 15. Pain Manag. 2019. PMID: 31613180 Free article. No abstract available.
The role of cannabinoids in pain control: the good, the bad, and the ugly.
Pergolizzi JV Jr, Lequang JA, Taylor R Jr, Raffa RB, Colucci D; NEMA Research Group. Pergolizzi JV Jr, et al. Minerva Anestesiol. 2018 Aug;84(8):955-969. doi: 10.23736/S0375-9393.18.12287-5. Epub 2018 Jan 16. Minerva Anestesiol. 2018. PMID: 29338150 Free article. Review.
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.
Lynch ME, Campbell F. Lynch ME, et al. Br J Clin Pharmacol. 2011 Nov;72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x. Br J Clin Pharmacol. 2011. PMID: 21426373 Free PMC article. Review.
98 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback